Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab for unresectable hepatocellular carcinoma: A single-arm, phase II study.

被引：0
|
作者：
Xu, Yongkang [1 ]
Fu, Shumin [1 ]
Mao, Ye [1 ]
Yi, Fengming [1 ]
Jiang, Weiming [1 ]
Feng, Long [1 ]
Wu, Jianbing [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
298-145-222-184-4809-5347; 281-5277-2622-5397; 281-5277-6771; 261-492-2769; 3282-3306-3348-4026; 283-2494; 613-135-244-3829-325; 3; 2; 28; 2424; 54; 239; 193; 1700; 4; 1; 38092-32104; 38116-38094-8;
D O I：
10.1200/JCO.2024.42.3_suppl.500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：500 / 500
页数：1
相关论文
共 50 条
  • [1] Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study
    Sun, Ruirui
    Gou, Yang
    Pan, Long
    He, Qiang
    Zhou, Yin
    Luo, Yi
    Wu, Chenrui
    Zhao, Yaowu
    Fu, Zixuan
    Huang, Ping
    CELLULAR ONCOLOGY, 2024,
  • [2] Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study
    Ruirui Sun
    Yang Gou
    Long Pan
    Qiang He
    Yin Zhou
    Yi Luo
    Chenrui Wu
    Yaowu Zhao
    Zixuan Fu
    Ping Huang
    Cellular Oncology, 2024, 47 (6) : 2277 - 2278
  • [3] A retrospective study exploring the safety and efficacy of hepatic arterial infusion chemotherapy and sequential transarterial embolization combined with lenvatinib and tislelizumab in unresectable hepatocellular carcinoma
    Zhong, Jian-Hong
    Chen, Zu-Shun
    Qi, Lu-Nan
    Zhang, Zhi-Ming
    Xiang, Bang-De
    Ma, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Hepatic artery infusion chemotherapy (HAIC) combined with tislelizumab and lenvatinib for initial unresectable hepatocellular carcinoma (HCC) with portal vein tumor thrombus: A prospective, single-arm phase II trial
    Pan, Long
    Sun, Ruirui
    He, Qiang
    Zhou, Yin
    Li, Jiachu
    Gou, Yang
    Wu, Chenrui
    Fu, Zixuan
    Zhao, Yaowu
    He, Qin
    Huang, Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] A single-arm, prospective study on the efficacy and safety of TACE-HAIC combined with lenvatinib and tislelizumab in the treatment of unresectable hepatocellular carcinoma.
    Zhu, Jun
    Feng, Xu
    Duan, Jintao
    Fu, Yu
    Liang, Jie
    Peng, Mi
    Zhu, Zimo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with unresectable hepatocellular carcinoma (HAIROX): A phase II, single-arm, prospective study.
    Chen, Shiguang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Efficacy of Shipixiaoji Granules, Lenvatinib, and Tislelizumab in Patients with Unresectable Hepatocellular Carcinoma: Protocol for a Prospective, Single-Arm, Phase II Trial
    Zhang, Zhen
    Liang, Zicheng
    Tan, Xiaoning
    Jian, Huiying
    Gao, Wenhui
    Zeng, Puhua
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (12)
  • [8] Hepatic arterial infusion chemotherapy sequential transarterial embolization combined with lenvatinib and tislelizumab in patients with high-risk unresectable hepatocellular carcinoma: A phase II trial
    Zhong, J-H.
    Deng, Z.
    Qi, L-N.
    Chen, Z-S.
    Zhang, Z-M.
    Xiang, B.
    Ma, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S1484 - S1484
  • [9] Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
    Jiang, Yi
    Su, Ke
    Li, Han
    Wang, Chenjie
    Wu, Zhenying
    Chen, Jiali
    Zhang, Zhiyao
    He, Kun
    Han, Yunwei
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 18 - 29
  • [10] Hepatic arterial infusion chemotherapy (HAIC) combined with tislelizumab and lenvatinib for advanced hepatocellular carcinoma (aHCC) with Vp3-4 portal vein tumor thrombosis (PVTT): A single-arm, phase II study
    Xu, Yongkang
    Fu, Shumin
    Mao, Ye
    Huang, Shenglan
    Li, Dan
    Wu, Jianbing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345